In each area, prevalence showed an increasing trend with age up to age 15 years. 2.2.3 Prevalence of HCV infection The nationwide prevalence of anti-HCV was 3.2% among those aged 1 to 59 years (range of prevalence in provinces: 0.9%–5.1%).
← all excerpts
Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.
1
—
—